Michael Clancy focuses on EU competition law, including advising clients on antitrust and cartel investigations, distribution, R&D collaborations, patent and trademark licensing and other commercial agreements, the clearance of mergers and joint ventures, and abuse of dominance issues.
Michael has significant experience in the life sciences (pharmaceuticals, biotech, and medical devices), cosmetics, and software & technology sectors.
His notable experience includes successfully defending clients in antitrust investigations by the European Commission in both the pharmaceutical and cosmetics sectors, his ongoing work on the appeal against the Commission's first decision on reverse-payment patent settlements in the pharma industry, as well as his ongoing work defending clients in the Commission’s auto-parts investigation.
Michael also has in-depth experience advising a range of clients on their distribution, licensing, and other collaboration agreements.
- Legal 500 for Healthcare and Life Sciences (‘Next Generation’ leading lawyer)
- Yale Law School, J.D., 2003
- University of Dayton, B.A. in Mechanical Engineering, 2000
Articles on competition law issues arising in the life sciences and other sectors.